MicroGenDX Press Releases | MicroGen Diagnostics

January 31, 2024

Study Unlocks New Hope in the Battle Against Male Infertility

A new study from UCLA and MicroGenDX shows that bacteria may be one of the factors holding back male fertility

November 7, 2023

MicroGenDX Next-Generation Sequencing Eliminates Post-Surgical Infections for Kidney Stone Removal in Groundbreaking Clinical Trial

Study shows MicroGenDX approach has the potential to revolutionize the prevention of postoperative infections.

February 24, 2023

MicroGenDX Next-Generation Sequencing PJI Study Named as JBJS Notable Article of 2022

The landmark 14-Site study on the role of Next-Generation Sequencing in Periprosthetic Joint Infections has been acknowledged by the journal as being one of the ten that “will have the greatest impact on patient care.”

August 9, 2022

Landmark 14-Site Study Demonstrates MicroGenDX Next-Generation Sequencing (NGS) Provides More Comprehensive Diagnosis of Periprosthetic Joint Infection

Largest study of its kind evaluates present and future role of NGS in orthopedic infections.

June 14, 2022

MicroGenDX Provides Rapid Screening for Candida Auris to Help Avoid Outbreaks in Healthcare Settings

Candida auris causes serious infections, and cases are rising across the U.S…..MicroGenDX testing also facilitates the rapid intervention and precautions needed to prevent outbreaks in healthcare settings by returning results within 24-48 hours.